Vorozole (Rivizor TM): an active and well tolerated new aromatase inhibitor for the treatment of advanced breast cancer patients with prior tamoxifen exposure

R Paridaens, JA Roy, M Nooij, Jan Klijn, SJ Houston, L VAM Beex, J Vinholes, E Tomiak, A van Vreckem, C Langenaeken, M Glabbeke, MJ Piccart

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)29-35
Number of pages7
JournalAnti-Cancer Drugs
Publication statusPublished - 1998

Cite this